Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate IV Dosing in Postmenopausal Osteoporosis
NCT00551174Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2004
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 4 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Oct 2004; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00551174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551174.